This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

3 Short-Squeeze Opportunities for 2011


Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Health diagnostics firm Alere (ALR - Get Report) has done a good job of rebounding since the company's name change from Inverness Medical this summer. But while shares are up 37% since July, the stock is still dealing with double-digit losses on the whole year. Alere's short ratio currently stands at 11.1.

By integrating its medical diagnostic devices with health management programs, Alere is tapping an attractive niche as demand for medical products moves higher alongside the aging population in the U.S. While the company has been able to regain its profitability in the latest quarter and full year, that move has been tentative at best in 2010.

Investors will want to see management sustain stronger operations before they'll be willing to bid share prices up. That said, with an attractive product and reasonable financial health, this stock should have rebound power in 2011... That's the hope of major shareholders, like Seth Klarman's Baupost Group. In addition to Alere, Klarman and company also own major stakes in ViaSat (VSAT) and News Corporation (NWSA). Other holders of the stock include David Dreman and Private Capital Management.
3 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
ALR $53.20 0.00%
BKS $8.30 0.48%
SHLD $16.73 -3.85%
AAPL $95.01 1.05%
FB $99.75 -4.15%


Chart of I:DJI
DOW 16,027.05 -177.92 -1.10%
S&P 500 1,853.44 -26.61 -1.42%
NASDAQ 4,283.7530 -79.3910 -1.82%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs